abstract |
The present invention relates to the use of at least one peptide of sequence VRLIVX1VRIX2RR (SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4), X1 being chosen from A or K and X 2 being chosen from W and K as a bactericidal antimicrobial agent against Listeria monocytogenes. |